Views
Janus sees big potential for Asian healthcare stocks
By
Joe Marsh
|
17 May 2010
Keywords:
janus
|
healthcare
|
andy acker
|
china
|
india
|
biotech
|
pharma
|
pharmaceuticals
China and India spend just 3% of GDP on healthcare, as against 16% in the US, but that figure is set to grow far faster than in developed markets, says Andy Acker of Janus Capital.
Articles older than 48 hours are available to subscribers only.
Paid subscribers have no limits.
Subscribe Now
or call +852 2122 5222
or email subscriptions@asianinvestor.net
Why subscribe?
- Unlimited access to the web site and mobile site, including video reports & web casts
- Full access to the historical archive of over 8,000 articles.
- 10 print & 10 e-magazines a year, plus back issue access
- Daily email news bulletins
- iPad & iPhone subscription access via the apps
- Regular supplements & reports
- Notification of relevant regional events,
- Up to 30% savings when buying the FULL package.